The abortion pill rulings are scaring the FDA and drugmakers — here’s why.
[ad_1] While Kacsmaryk stayed his decision until Friday and the Biden administration has already appealed to the 5th U.S. Circuit Court of Appeals, the ramifications from Friday’s decision for the FDA and the drug industry could be felt for decades regardless of how this case is ultimately decided. Here’s what we know: Will the decision…